10-Q: TruGolf Holdings Completes Business Combination, Reports Q3 2024 Results

TruGolf Holdings, formerly Deep Medicine Acquisition Corp., completed its business combination and reported financial results for the quarter ended December 31, 2023, prior to the merger.

Summary

• TruGolf Holdings, previously known as Deep Medicine Acquisition Corp., has released its financial results for the quarter ended December 31, 2023.
• The company completed a business combination on January 31, 2024, merging with TruGolf, Inc. and changing its name to TruGolf Holdings, Inc.
• The company's Class A common stock began trading on the Nasdaq Capital Market under the ticker symbol TRUG on February 1, 2024.
• Prior to the merger, the company's financial statements show a net loss of $359,954 for the three months ended December 31, 2023, and a net loss of $891,865 for the nine months ended December 31, 2023.
• The company had cash of $177,876 and marketable securities held in a trust account of $6,703,330 as of December 31, 2023.
• The company's working capital deficit was $3,527,747 as of December 31, 2023.
• The company has incurred significant costs in pursuit of its acquisition plans and will not generate any operating revenues until after the completion of its initial business combination.
• The company has an accumulated deficit of $7,789,256 as of December 31, 2023.

Sentiment

Score: 4

Explanation: The document highlights the successful completion of a business combination, but the financial results show significant losses and a working capital deficit. The company's reliance on additional capital raises and the identified material weakness in internal controls temper the positive aspects of the merger.

Positives

• The successful completion of the business combination with TruGolf, Inc. marks a significant milestone for the company.
• The company's Class A common stock is now trading on the Nasdaq Capital Market under the ticker symbol TRUG, providing increased visibility and potential liquidity.
• The company has secured a PIPE investment of up to $15,500,000 in convertible notes and warrants.

Negatives

• The company reported a net loss of $359,954 for the three months ended December 31, 2023, and a net loss of $891,865 for the nine months ended December 31, 2023.
• The company had a working capital deficit of $3,527,747 as of December 31, 2023.
• The company has an accumulated deficit of $7,789,256 as of December 31, 2023.
• The company's disclosure controls and procedures were deemed not effective due to inadequate segregation of duties and insufficient written policies and procedures.

Risks

• The company has incurred significant costs in pursuit of its acquisition plans and will not generate any operating revenues until after the completion of its initial business combination.
• The company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties.
• The company's ability to continue as a going concern is dependent on its ability to raise capital and generate sufficient cash flows.
• The company's disclosure controls and procedures were not effective as of the end of the period covered by this report, due to the inadequate segregation of duties within our account processes.
• The company's financial results may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets.

Future Outlook

The company expects to incur significant costs in pursuit of its acquisition plans and will not generate any operating revenues until after the completion of its initial business combination. The company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties.

Management Comments

• The company's management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units.
• The company's management continues to evaluate the impact of the COVID-19 pandemic on the industry.
• Management of the company does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the company's financial statements.

Industry Context

This announcement reflects the completion of a business combination, a common strategy for special purpose acquisition companies (SPACs) to go public. The company's transition from a blank check company to an operating entity is a typical progression in the SPAC lifecycle. The financial results reflect the pre-merger status of the company and are not indicative of the post-merger performance of TruGolf Holdings.

Comparison to Industry Standards

• The financial performance of Deep Medicine Acquisition Corp. prior to the merger is typical of a SPAC, with minimal operating activity and reliance on interest income from trust account holdings.
• The net losses reported are consistent with the pre-revenue nature of SPACs before a business combination.
• The working capital deficit is not unusual for a SPAC that has incurred expenses related to the pursuit of a business combination.
• The redemption of shares by public stockholders is a common occurrence in SPAC transactions, and the company's experience is consistent with industry trends.
• The company's reliance on related party loans and sponsor support is also a typical characteristic of SPACs.
• The PIPE investment secured by the company is a common mechanism for SPACs to raise additional capital in connection with a business combination.
• The company's transition to TruGolf Holdings and its listing on Nasdaq is a standard outcome for a successful SPAC merger.

Related Party Transactions

• The company had loans payable to the Sponsor and its affiliates in the amount of $2,065,000 as of December 31, 2023.
• The company pays monthly fees to its former Chief Financial Officer.
• The company will issue 300,000 post business combination shares to its officers and directors.

Stakeholder Impact

• Shareholders of Deep Medicine Acquisition Corp. have seen their shares converted into shares of TruGolf Holdings, Inc.
• TruGolf shareholders have received shares of TruGolf Holdings, Inc. as part of the merger.
• The company's employees will now be part of the combined entity.
• The company's customers and suppliers will be impacted by the merger and the new entity's operations.
• Creditors of the company will be impacted by the merger and the new entity's financial performance.

Next Steps

• The company will focus on integrating TruGolf's operations and executing its business plan.
• The company will need to manage its working capital and potentially seek additional financing.
• The company will need to address the material weakness in its internal controls.
• The company will need to meet the milestones specified in the Restated Merger Agreement to earn the contingent earnout shares.

Key Dates

Keywords

business combination, TruGolf, SPAC, merger, Nasdaq, financial results, convertible notes, warrants, working capital, redemption, PIPE investment